Standard Biotools | FLDM - Ebitda

Aktienkurs
0.88
Täglich Wechseln
-0.01 -1.57%
Monatlich
-11.14%
Jährlich
-14.95%
Q2 Prognose
0.88




Ebitda Veränderung Datum
Agilent USD 540M 74M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Bio-Rad Laboratories USD -374.6M 841.8M 2025-09
Bruker USD 211.6M 207.4M 2025-12
Danaher USD 2.13B 252M 2025-12
Illumina USD 332M 12M 2025-09
Myriad Genetics USD 14.3M 4M 2025-12
Nikon Corporation JPY 7.27B 1.85B 2025-09
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Revvity USD 248.91M 48.52M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sony JPY 788.04B 76.88B 2025-12
Standard Biotools USD -15.81M 734K 2025-12
Thermo Fisher Scientific USD 3.17B 335M 2025-12
Waters USD 380.97M 85.83M 2025-12